U.S. private equity firm SK Capital Partners is approaching a deal to buy Swixx Biopharma SA, a Swiss-based pharmaceutical distributor, Bloomberg News reported Sunday, citing people familiar with the ...

The S&P 500 stalled just below record highs last week, with higher timeframe analysis pointing to a bullish bias and a clear ...

Read thorough research and investment insights by Josh Coe on Seeking Alpha here. View their credentials, investment style, ...

Invesco Charter Fund’s Class A shares at net asset value returned 6.50% for the quarter, underperforming the Russell 1000 ...

According to the Financial Times, trading in credit default swaps, which serve as insurance against defaults, has surged by ...

Discover 10 undervalued healthcare stocks and why pharmaceuticals and providers stand out for value and quality.

Oracle's CapEx-to-revenue ratio has gone from 13% in FY2024 to 37% in FY2025 to an estimated 75% in FY2026. But their CapEx-to-infrastructure revenue ratio can range from 101% to 206%. This is a tax ...

On the revenue front, Zscaler continued to see strong momentum with its large customers, where $100K+ and $1M+ ARR (Annual Recurring Revenue) customers grew at a CAGR of 18% and 22%, respectively, ...

Patria Investments (PAX) grows fee-earning AUM 13% to $44B with two acquisitions, boosting private credit and REIT exposure.

Meridian Corporation remains a 'buy' as deposit growth, strong asset quality, and attractive valuation persist. MRBK's net ...

Discover why Newmont (NEM) is poised for growth with strong cash flow, a solid balance sheet, and undervalued trading—read ...

Discover why UiPath’s AI-powered RPA platform, strong growth, and compelling valuation make PATH stock a smart buy.